Paul Woods

Paul woods compliance · Compliance

Background A key task for the pharmaceutical industry is to understand the compliance implications of engaging with a patient advocacy group (PAG). This presents challenges for the industry to negotiate the ethical and reputational issues that can arise when working with a PAG. Objective To gain the views of pharmaceutical industry executives on f...

The international pharmaceutical industry has made significant efforts towards ensuring compliant and ethical communication and interaction with physicians and patients. This article presents the current status of the worldwide governance of communication practices by pharmaceutical companies, concentrating on prescription-only medicines. It analyz...

A randomised, comparative study is reported of single intravenous doses of cephradine 2 g or cefuroxime 1.5 g given as prophylactic cover for total hip replacements in 40 patients. The serum and bone levels of cephalosporin achieved were higher in the cephradine treated group in proportion to the higher dose employed. Both agents provided adequate...

Amoxycillin and trimethoprim were compared in 50 children with acute otitis media. Both antibiotics relieved symptoms and were well tolerated. No statistically significant differences between the groups were found. It is proposed that trimethoprim is a suitable alternative to amoxycillin in children who are allergic to penicillin.

Percival A and Woods P (editors) Royal Soc Med Congress and Symposium Series 1985 no.85 "Cephradine 12 years on"

Williams J.D. and Woods P (editors) Royal Soc Med Congress and Symposium, Series 1985 no.89

Oral candidosis and nystatin pastilles Woods P and Martin M.V. Br J Pharm Pract 1985 7:222 "Oral candidosis and nystatin pastilles

Investigation of the Comparative liposolubilities of beta adrenoreceptor blocking agents"